First Allied Advisory Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

First Allied Advisory Services’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-46,100	Closed	-$413K	–	1234
2020 Q2	$413K	Buy	46,100 +185	+0.4%	+$1.72K	0.02%	712
2020 Q1	$292K	Hold	45,915	–	–	0.01%	768
2019 Q4	$385K	Buy	45,915 +10,000	+28%	+$92K	0.01%	810
2019 Q3	$325K	Buy	35,915 +5,800	+19%	+$65.1K	0.01%	854
2019 Q2	$324K	Buy	30,115 +14,000	+87%	+$149K	0.01%	854
2019 Q1	$154K	Sell	16,115 -84	-0.5%	-$858	0.01%	1080
2018 Q4	$185K	Hold	16,199	–	–	0.01%	972
2018 Q3	$273K	Buy	+16,199	New	+$246K	0.01%	952

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Allied Advisory Services's SGMO Position: Q3 2020 in Review

First Allied Advisory Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2020, closing a stake of 46,100 shares — an estimated $413K sold.

First Allied Advisory Services first reported a position in SGMO in Q3 2018 and held it in 8 quarters. The position peaked at $413K in Q2 2020. 210 funds tracked by Wall St. Rank hold SGMO as of Q3 2020.

First Allied Advisory Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2020 after selling out during the quarter.
First Allied Advisory Services sold 46,100 SANGAMO THERAPEUTICS INC shares in Q3 2020, an estimated $413K.
First Allied Advisory Services first reported a position in SANGAMO THERAPEUTICS INC in Q3 2018 and held it in 8 quarters.
First Allied Advisory Services's SANGAMO THERAPEUTICS INC position peaked at $413K in Q2 2020.
210 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.